Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1951 1
1952 3
1954 1
1955 6
1956 1
1957 3
1958 3
1959 2
1960 5
1961 2
1963 2
1964 3
1965 5
1966 2
1967 4
1968 3
1969 7
1970 8
1971 6
1972 3
1973 1
1975 1
1976 1
1977 3
1978 1
1979 1
1980 1
1981 5
1982 3
1984 7
1985 6
1986 5
1987 6
1988 6
1989 9
1990 6
1991 9
1992 3
1993 3
1994 4
1995 5
1996 5
1997 8
1998 6
1999 6
2000 8
2001 9
2002 13
2003 16
2004 11
2005 18
2006 12
2007 8
2008 19
2009 17
2010 19
2011 23
2012 26
2013 29
2014 32
2015 23
2016 19
2017 28
2018 27
2019 26
2020 23
2021 30
2022 25
2023 31
2024 32
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

648 results

Results by year

Filters applied: . Clear all
Page 1
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.
Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Hart L, Campone M, Petrakova K, Winer EP, Janni W, Conte P, Cameron DA, André F, Arteaga CL, Zarate JP, Chakravartty A, Taran T, Le Gac F, Serra P, O'Shaughnessy J. Hortobagyi GN, et al. Among authors: serra p. N Engl J Med. 2022 Mar 10;386(10):942-950. doi: 10.1056/NEJMoa2114663. N Engl J Med. 2022. PMID: 35263519 Clinical Trial.
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 Study.
Lazzeroni M, Puntoni M, Guerrieri-Gonzaga A, Serrano D, Boni L, Buttiron Webber T, Fava M, Briata IM, Giordano L, Digennaro M, Cortesi L, Falcini F, Serra P, Avino F, Millo F, Cagossi K, Gallerani E, De Simone A, Cariello A, Aprile G, Renne M, Bonanni B, DeCensi A. Lazzeroni M, et al. Among authors: serra p. J Clin Oncol. 2023 Jun 10;41(17):3116-3121. doi: 10.1200/JCO.22.02900. Epub 2023 Mar 14. J Clin Oncol. 2023. PMID: 36917758 Clinical Trial.
Expanding antigen-specific regulatory networks to treat autoimmunity.
Clemente-Casares X, Blanco J, Ambalavanan P, Yamanouchi J, Singha S, Fandos C, Tsai S, Wang J, Garabatos N, Izquierdo C, Agrawal S, Keough MB, Yong VW, James E, Moore A, Yang Y, Stratmann T, Serra P, Santamaria P. Clemente-Casares X, et al. Among authors: serra p. Nature. 2016 Feb 25;530(7591):434-40. doi: 10.1038/nature16962. Epub 2016 Feb 17. Nature. 2016. PMID: 26886799
Nanoparticle-based autoimmune disease therapy.
Serra P, Santamaria P. Serra P, et al. Clin Immunol. 2015 Sep;160(1):3-13. doi: 10.1016/j.clim.2015.02.003. Epub 2015 Feb 19. Clin Immunol. 2015. PMID: 25704658 Review.
Gel Blot Hybridization for Viroids.
Serra P. Serra P. Methods Mol Biol. 2022;2316:97-109. doi: 10.1007/978-1-0716-1464-8_10. Methods Mol Biol. 2022. PMID: 34845689
Viroids: survivors from the RNA world?
Flores R, Gago-Zachert S, Serra P, Sanjuán R, Elena SF. Flores R, et al. Among authors: serra p. Annu Rev Microbiol. 2014;68:395-414. doi: 10.1146/annurev-micro-091313-103416. Epub 2014 Jun 18. Annu Rev Microbiol. 2014. PMID: 25002087 Review.
[Histopathology of Orf].
Serra P, Bernard J, Lavrut PM, Balme B. Serra P, et al. Ann Dermatol Venereol. 2013 Aug-Sep;140(8-9):571-3. doi: 10.1016/j.annder.2013.05.001. Epub 2013 Jun 21. Ann Dermatol Venereol. 2013. PMID: 24034646 French. No abstract available.
648 results